Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Frequently asked questions
What sector does Predictive Oncology Inc (POAI) operate in?
Predictive Oncology Inc belongs to the Healthcare sector and operates in the Software - Infrastructure industry.
What is Predictive Oncology Inc (POAI) current stock price?
As of the latest data, Predictive Oncology Inc stock price is $5.95, with a previous close of $5.95.
What is Predictive Oncology Inc (POAI) current market capitalization?
Predictive Oncology Inc market cap is approximately 20.19 million.
What is Predictive Oncology Inc (POAI) Earnings Per Share (EPS)?
The trailing EPS is -$141.32.
Does Predictive Oncology Inc (POAI) pay dividends?
No. Predictive Oncology Inc does not pay a dividend.
What is Predictive Oncology Inc (POAI) beta (volatility) score?
Predictive Oncology Inc has a beta of 1.353, suggesting it is more volatile than the market.
